Betty Jo Rocchio - Oct 9, 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Director
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Stock symbol
TELA
Transactions as of
Oct 9, 2025
Transactions value $
$0
Form type
4
Date filed
10/10/2025, 04:07 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rocchio Betty Jo Director C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN /s/ Megan Smeykal, Attorney-in-Fact 2025-10-10 0002089250

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +11.9K $0.00 11.9K Oct 9, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +17.6K $0.00 17.6K Oct 9, 2025 Common Stock 17.6K $1.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in three equal annual installments beginning on October 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2 The option vests in 36 equal monthly installments on each monthly anniversary of October 9, 2025, in each case subject to the Reporting Person's continued service through the applicable vesting date.